Search

Pages

1. • Journal article

   • 

   Symptoms and patient-reported well-being: Do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma

   Bottomley, Andrew[UCL] Coens, Corneel Efficace, Fabio Gaafar, Rabab Manegold, Christian Burgers, Sjaak Vincent, Mark Legrand, Catherine[UCL] van Meerbeeck, Jan P. (2007) Journal of Clinical Oncology — Vol. 25, no. 36, p. 5770-5776 (2007)
2. • Journal article

   • 

   Comparison of different estimation procedures for proportional hazards model with random effects

   Cortinas Abrahantes, Jose Legrand, Catherine[UCL] Burzykowski, Tomasz Janssen, Paul Ducrocq, Vincent Duchateau, Luc (2007) Computational Statistics & Data Analysis — Vol. 51, no. 8, p. 3913-3930 (2007)
3. • Journal article

   • 

   Heterogeneity in disease free survival between centers: lessons learned from an EORTC breast cancer trial

   Legrand, Catherine[UCL] Duchateau, L. Sylvester, Richard J.[UCL] Janssen, P. van der Hage, JA van de Velde, CJH Therasse, Patrick (2006) Clinical Trials — Vol. 3, no. 1, p. 10-18 (2006)
4. • Journal article

   • 

   Incidence and risk factors for adverse events during monitored anaesthesia care for gastrointestinal endoscopy in children: A prospective observational study.

   Najafi, Nadia Veyckemans, Francis Vanhonacker, Domien Legrand, Catherine[UCL] Van de Velde, Anne Vandenplas, Yvan Poelaert, Jan (2019) European journal of anaesthesiology — Vol. 36, no.6, p. 390-399 (2019)
5. • Journal article

   • 

   Implementing patient-reported health-related quality-of-life data in cancer routine practice to improve accuracy of prognosis. Are we there yet?

   Legrand, Catherine[UCL] Efficace, Fabio (2009) Expert review of pharmacoeconomics & outcomes research — Vol. 9, no. 6, p. 493-6 (2009)
6. • BookChapter

   • 

   Cure models in oncology clinical trials

   Legrand, Catherine[UCL] Bertrand, Aurélie[UCL] (2019) Textbook of Clinical Trials in Oncology : A Statistical Perspective (1st Edition) — [ISBN : 9781138083776]
7. • Journal article

   • 

   Joint longitudinal and time-to-event cure models for the assessment of being cured.

   Barbieri, Antoine[UCL] Legrand, Catherine[UCL] (2019) Statistical methods in medical research — Vol. 29, no. 4, p. 1256-1270 (2020)
8. • Journal article

   • 

   Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country

   Molenberghs, Geert Buyse, Marc Abrams, Steven Hens, Niel Beutels, Philippe Faes, Christel Verbeke, Geert Van Damme, Pierre Goossens, Herman Neyens, Thomas Herzog, Sereina Theeten, Heidi Pepermans, Koen Abad, Ariel Alonso Van Keilegom, Ingrid[UCL] Speybroeck, Niko[UCL] Legrand, Catherine[UCL] De Buyser, Stefanie Hulstaert, Frank (2020) Contemporary Clinical Trials — Vol. 99, p. 106189 (2020)
9. • Journal article

   • 

   Safety of long-term of retrograde-intermittent pneumatic compression in lower limb lymphoedema

   Theys, Serge[UCL] Deltombe, Thierry[UCL] Scavée, V.[UCL] Legrand, Catherine[UCL] Schoevaerdts, J.C.[UCL] (2002) Lymphology — Vol. 35, no.Suppl, p. 293-297 (2002)
10. • Journal article

    • 

    Waiting period from diagnosis for mortgage insurance issued to cancer survivors

    Soetewey, Antoine[UCL] Legrand, Catherine[UCL] Denuit, Michel[UCL] Silversmit, Geert (2021) European Actuarial Journal — Vol. 11, p. 135-160 (2021)
11. • Journal article

    • 

    Flexible parametric approach to classical measurement error variance estimation without auxiliary data : Classical Measurement Error Variance Estimation

    Bertrand, Aurélie[UCL] Van Keilegom, Ingrid[UCL] Legrand, Catherine[UCL] (2019) Biometrics — Vol. 75, no. 1, p. 297-307 (2019)
12. • Journal article

    • 

    Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans

    Burny, Wivine Marchant, Arnaud Hervé, Caroline Callegaro, Andrea Caubet, Magalie Fissette, Laurence Gheyle, Lien Legrand, Catherine[UCL] Ndour, Cheikh[UCL] Tavares Da Silva, Fernanda van der Most, Robbert Willems, Fabienne Didierlaurent, Arnaud M. Yarzabal, Juan (2019) Vaccine — Vol. 37, no.14, p. 2004-2015 (2019)
13. • Journal article

    • 

    A note on tests for relevant differences with extremely large sample sizes

    Callegaro, Andrea Ndour, Cheikh[UCL] Aris, Emmanuel Legrand, Catherine[UCL] (2019) Biometrical Journal — Vol. 61, no.1, p. 162-165 (2019)
14. • Journal article

    • 

    A new measure of treatment effect in clinical trials involving competing risks based on generalized pairwise comparisons

    Cantagallo, Eva De Backer, Mickaël[UCL] Kicinski, Michal Ozenne, Brice Collette, Laurence Legrand, Catherine[UCL] Buyse, Marc Péron, Julien (2020) Biometrical Journal — Vol. 63, no. 2, p. 272-288 (2020)
15. • Journal article

    • 

    The Single-Index/Cox Mixture Cure Model

    Amico, Maïlis Van Keilegom, Ingrid Legrand, Catherine[UCL] (2019) Biometrics — Vol. 75, p. 452-462 (2019)
16. • Journal article

    • 

    Vertical modeling: analysis of competing risks data with a cure fraction

    Nicolaie, Mioara Alina[UCL] Taylor, Jeremy M. G. Legrand, Catherine[UCL] (2019) Lifetime Data Analysis — Vol. 25, no.1, p. 1-25 (2019)
17. • Book

    • 

    Advanced Survival Models

    Legrand, Catherine[UCL] (2021)
18. • Journal article

    • 

    A Bayesian approach to jointly estimate centre and treatment by centre heterogeneity in a proportional hazards model

    Legrand, Catherine[UCL] Ducrocq, V. Janssen, P. Sylvester, Richard J.[UCL] Duchateau, L. (2005) Statistics in Medicine — Vol. 24, no. 24, p. 3789-3804 (2005)
19. • Journal article

    • 

    European Organization for Research and Treatment of Cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer

    Ardizzoni, A. Manegold, C. Debruyne, Channa[UCL] Gaafar, R. Buchholz, E. Smit, E. F. Lianes, P. ten Velde, G. Bosquée, L.[UCL] Legrand, Catherine[UCL] Neumaier, C. King, K. Giaccone, Giuseppe (2003) Clinical Cancer Research — Vol. 9, no. 1, p. 143-150 (2003)
20. • WorkingPaper

    • 

    A randomized phase II study comparing two schedules of the 21-day regime of Gemcitabine and Carboplatin in advanced NSCLC

    Surmont, V. Aerts, J. Van Klaveren, R.J. Tournoy, K. Tan, K. Vernhout, R.M. Schmitz, P.I.M. Legrand, Catherine[UCL] Hoogsteden, H.C. Van Meerbeeck, J.P. (2009)
21. • WorkingPaper

    • 

    Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor as biomarkers of mesothelioma

    Hollevoet, K. Kellen, E. Thimpont, J. Germonpré, P. De Vuyst, P. Bosquée, L. Legrand, Catherine[UCL] Kishi, Y. Nackaerts, K. Delanghe, J.R. Van Meerbeeck, J.P. (2009)
22. • Journal article

    • 

    Short-term treatment-related symptoms and quality of life: Results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study

    Bottomley, Andrew Vincent, Marie-Françoise[UCL] Gaafa, R Manegold, C. Burgers, S Coens, Corneel Legrand, Catherine[UCL] Giaccone, Giuseppe van Meerbeeck, J. (2006) Journal of Clinical Oncology — Vol. 24, no. 9, p. 1435-1442 (2006)
23. • Journal article

    • 

    Three-Arm Randomized Study of Two Cisplatin-Based Regimens and Paclitaxel Plus Gemcitabine in Advanced Non–Small-Cell Lung Cancer : A Phase III Trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group—EORTC 08975

    Smit, Egbert, F. van Meerbeeck, Jan P.A.M. Lianes, Pilar Debruyne, Channa Legrand, Catherine[UCL] Schramel, Franz Smit, Hans Gaafar, Rabab Biesma, Bonne Manegold, Chris Neymark, Niels Giaccone, Giuseppe (2003) Journal of Clinical Oncology — Vol. 21, no. 21, p. 3909-3917 (2003)
24. • Book

    • 

    Assessing Heterogeneity in Clinical Trials Using the Frailty Model : Quantifying, interpreting and explaining heterogeneity over centers in multicenter cancer clinical trials

    Legrand, Catherine[UCL] (2009)
25. • Journal article

    • 

    Standard Versus Intensified Chemotherapy With Granulocyte Colony-Stimulating Factor Support in Small-Cell Lung Cancer : A Prospective European Organization for Research and Treatment of Cancer–Lung Cancer Group Phase III Trial—08923

    Ardizzoni, Andrea Tjan-Heijnen, Vivianne C. G. Postmus, Pieter E. Buchholz, Erica Biesma, Bonne Karnicka-Mlodkowska, Hanna Dziadziusko, Rafal Burghouts, Jos Van Meerbeeck, Jan P. Gans, Stevens Legrand, Catherine[UCL] Debruynne, Channa Giaccone, Giuseppe (2002) Journal of Clinical Oncology — Vol. 20, no. 19, p. 3947-3955 (2002)

Pages